La FDA approva atezolizumab per il trattamento adiuvante del tumore della vescica muscolo …
The U.S. Food and Drug Administration (FDA) has expanded the approved use of atezolizumab, a targeted immunotherapy, to include the adjuvant treatment of patients with muscle-invasive … Read more